Belgian Court Clears Genzyme to Acquire Pharming Unit | GenomeWeb

NEW YORK, Oct. 30 – Genzyme was given the green light from a court in Belgium to acquire rival Pharming NV, currently in receivership, Genzyme said on Tuesday.

Pharming Group, the subsidiary’s parent company, said it plans to appeal the ruling. In September, the company said it opposed an offer from Genzyme because the bid was too low.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.